Aspen stock holds near 52-week high amid steady trading

Aspen Pharmacare Holdings Ltd. stock (ISIN ZAE000066692) traded at around ZAR 15,726 on September 16, 2026 on its Johannesburg listing, placing the South African pharmaceutical group close to its 52-week high of ZAR 16,093 and underpinning a market capitalization of about ZAR 69.83 billion as investors weigh its earnings and dividend profile.

Share price near top of 52-week range

According to price data for Aspen Pharmacare Holdings referenced by a recent equity overview, the shares closed at ZAR 15,726 on September 16, 2026, with the same level reported as the prior close, indicating a flat session at the end of that trading day.

The same data set shows that on that day the stock traded between an intraday low of ZAR 15,524 and an intraday high of ZAR 15,890, within a documented 52-week range stretching from ZAR 9,070 at the low to ZAR 16,093 at the high, meaning the September 16, 2026 closing price stood much nearer the top than the bottom of the past year’s corridor.

Earnings, dividend yield and payout metrics

A recent metrics summary for Aspen Pharmacare Holdings indicates that, over the last twelve months, the company’s earnings per share (EPS) metric used in that overview stood at about negative 4 on a rolling basis, while a listed dividend yield of 1.48 percent was slightly below the referenced industry median of 1.50 percent, implying a modest income stream for shareholders relative to sector peers.

The same summary cites an annualized payout figure of roughly 232 on its internal scale and notes that retained earnings over the period reflected a negative 4.07 percent, suggesting that distributions and other capital allocation decisions have outweighed retained profit in the most recent cycle captured by the portal’s data.

Revenue scale and valuation context

In addition, the equity overview reports revenue of about ZAR 17.08 billion for the company within the period captured by its latest update, providing a sense of Aspen’s top-line scale against its ZAR 69.83 billion market capitalization, which implies that the shares are currently valued at roughly four times the revenue figure highlighted in the portal.

From an investor’s perspective, the combination of a negative rolling EPS figure, a dividend yield of about 1.48 percent and a price level near the 52-week high places the focus on how quickly Aspen can improve profitability and earnings quality in upcoming reporting periods to justify the current valuation multiples.

Stock level and investor takeaway

As of the last completed trading day before September 20, 2026, Aspen Pharmacare Holdings stock was therefore trading at ZAR 15,726 on its primary listing on the Johannesburg Stock Exchange, close to the 52-week high of ZAR 16,093 and underpinned by a market capitalization of about ZAR 69.83 billion based on that price, with investors watching future earnings and dividend developments to assess whether the current valuation remains sustainable.

More news and analyses on Aspen Pharmacare Holdings stock